112 related articles for article (PubMed ID: 37475542)
1. Planning vascular access creation: The promising role of the kidney failure risk equation.
Marques da Silva B; Dores M; Silva O; Pereira M; Outerelo C; Fortes A; Lopes JA; Gameiro J
J Vasc Access; 2023 Jul; ():11297298231186373. PubMed ID: 37475542
[TBL] [Abstract][Full Text] [Related]
2. Validation of the kidney failure risk equation in a Portuguese cohort.
da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
[TBL] [Abstract][Full Text] [Related]
3. Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making.
Atiquzzaman M; Zhu B; Romann A; Er L; Djurdjev O; Bevilacqua M; Wong MMY; Birks P; Yi TW; Singh A; Tangri N; Levin A
Clin Kidney J; 2024 Feb; 17(2):sfae008. PubMed ID: 38327282
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
Lundström UH; Ramspek CL; Dekker FW; van Diepen M; Carrero JJ; Hedin U; Evans M
Nephrol Dial Transplant; 2024 Mar; ():. PubMed ID: 38486367
[TBL] [Abstract][Full Text] [Related]
5. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.
Thanabalasingam SJ; Iliescu EA; Norman PA; Day AG; Akbari A; Hundemer GL; White CA
Kidney Med; 2022 Apr; 4(4):100440. PubMed ID: 35445190
[TBL] [Abstract][Full Text] [Related]
6. Death and Dialysis Following Discharge From Chronic Kidney Disease Clinic: A Retrospective Cohort Study.
Che M; Iliescu E; Thanabalasingam S; Day AG; White CA
Can J Kidney Health Dis; 2022; 9():20543581221118434. PubMed ID: 35992302
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Kidney Failure Risk Equation in Manitoba.
Whitlock RH; Chartier M; Komenda P; Hingwala J; Rigatto C; Walld R; Dart A; Tangri N
Can J Kidney Health Dis; 2017; 4():2054358117705372. PubMed ID: 28491341
[TBL] [Abstract][Full Text] [Related]
8. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study.
Maher F; Teece L; Major RW; Bradbury N; Medcalf JF; Brunskill NJ; Booth S; Gray LJ
Diagn Progn Res; 2023 Oct; 7(1):22. PubMed ID: 37798742
[TBL] [Abstract][Full Text] [Related]
9. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients.
Tangri N; Ferguson TW; Wiebe C; Eng F; Nash M; Astor BC; Lam NN; Ye F; Shin JI; Whitlock R; Yuen DA
Can J Kidney Health Dis; 2020; 7():2054358120922627. PubMed ID: 32549052
[TBL] [Abstract][Full Text] [Related]
11. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
[TBL] [Abstract][Full Text] [Related]
12. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
[TBL] [Abstract][Full Text] [Related]
13. Is there a role of the kidney failure risk equation in optimizing timing of vascular access creation in pre-dialysis patients?
Kuningas K; Stringer S; Cockwell P; Khawaja A; Inston N
J Vasc Access; 2023 Nov; 24(6):1305-1313. PubMed ID: 35343295
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis.
Park KJ; Benuzillo JG; Keast E; Thorp ML; Mosen DM; Johnson ES
Perm J; 2021 Dec; 25():. PubMed ID: 35348109
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound Parameters.
Akbari A; Tangri N; Brown PA; Biyani M; Rhodes E; Kumar T; Shabana W; Sood MM
Can J Kidney Health Dis; 2020; 7():2054358120911274. PubMed ID: 32215214
[TBL] [Abstract][Full Text] [Related]
16. Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care.
Li K; Pirabhahar S; Thomsett M; Turner K; Wainstein M; Ha JT; Katz I
Intern Med J; 2024 Mar; ():. PubMed ID: 38532529
[TBL] [Abstract][Full Text] [Related]
17. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.
Lennartz CS; Pickering JW; Seiler-Mußler S; Bauer L; Untersteller K; Emrich IE; Zawada AM; Radermacher J; Tangri N; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2016 Apr; 11(4):609-15. PubMed ID: 26787778
[TBL] [Abstract][Full Text] [Related]
18. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
Ali I; Donne RL; Kalra PA
BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
[TBL] [Abstract][Full Text] [Related]
19. The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study.
Ahmed S; Mothi SS; Sequist T; Tangri N; Khinkar RM; Mendu ML
Kidney Med; 2022 Jan; 4(1):100375. PubMed ID: 35072040
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort.
Ramírez Medina CR; Ali I; Baricevic-Jones I; Saleem MA; Whetton AD; Kalra PA; Geifman N
Clin Proteomics; 2024 May; 21(1):34. PubMed ID: 38762513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
